Interestingly, the presence of fecal microbiota clearly triggered IL-22 production in human LPMCs (63) and potential differences in the composition of the gut microbiota might thus explain, at least partly, the controversy of published data on the intestinal IL-22 levels in IBD patients. Here, IL22 is linked to inflammatory bowel disease.